Please click “Session Code” for the detailed program.
* as of July 17, 2018
| Time | Walker Hall 1 (1F) | Walker Hall 2 (1F) | Cosmos Hall (3F) | Art Hall (4F) |
|---|---|---|---|---|
| 08:00-10:00 | SY 01 (Kor) * 필수 교육 (2평점) | Pre-congress 02 | ||
| The current status of healthcare-associated infection (HAI) and the role of clinical microbiology | (08:30-16:30) MSACL Clinical mass spectrometry workshop |
|||
| 10:00-12:00 | SY 02 (Kor) | Pre-congress 01 | ||
| Inspector workshop of the Korean laboratory accreditation program | (10:30-16:00) Patient-centered laboratory medicine (Women's health, Cardiac disease, Oncology) |
|||
| 13:00-15:00 | SY 03 (Kor) * 필수 교육 | |||
| Education course for laboratory medicine specialist | ||||
| 15:00-17:00 | SY 04 (Kor) | |||
| MFDS-KSLM Session In vitro diagnostics device registration and modification for MFDS |
||||
| 17:00-17:30 | Opening Ceremony (Walkerhill Theatre, B1) |
|||
| 17:30-18:30 | PL 01 | |||
| Blood type and personality – Asian mythology (Walkerhill Theatre, B1) |
||||
| 18:30-20:00 | Welcome Reception (Vista Hall 1, B2) |
|||
| Time | Vista Hall 1 (B2) | Walker Hall 1 (1F) | Walker Hall 2 (1F) | Cosmos Hall (3F) | Art Hall (4F) |
|---|---|---|---|---|---|
| 08:00-08:40 | KS 01 | SY 06 | |||
| Clinical pathologists and taking care of patients in the clinic | (08:00-10:30) Clinical laboratory reimbursement – Financial aspects of laboratory medicine |
||||
| 08:40-10:40 | SY 05 | SY 07 | OP 01 | Senate Meeting (09:30-11:00) |
|
| Statistics & ethics for laboratory researches | (09:00-10:40) New molecular technologies for personalized medicine |
Clinical chemistry 1 | |||
| 10:40-11:00 | Break | ||||
| 11:00-12:00 | PL 02 | ||||
| AACC-KSLM Select Session Expanding the measurable metabolome: How should we mine the lipidome? |
|||||
| 12:00-13:00 | EW 01 | EW 02 | EW 03 | EW 04 | EW 05 |
 Review on potential biotin interference in immunoassays |
 Atellica solution workflow - Doing more with less |
Roche Diagnostics Korea cobas pro integrated solutions - Simplicity meets excellence |
 Significance of full panel assays in syndromic diagnosis for infectious diseases |
 Evaluation of new isothermal amplification molecular diagnostic method for the diagnosis of Influenza infection |
|
| 13:00-14:40 | SY 08 | SY 09 | SY 10 | OP 02 | OP 03 |
| Practical aspects of laboratory management Ⅳ; Laboratory Information System (LIS) & Information Communication Technology (ICT) | Education track I | Genomics of human leukocyte antigen (HLA) in the era of next generation sequencing (NGS) | Clinical microbiology | General Laboratory Medicine & Transfusion Medicine | |
| 14:40-15:00 | Break | ||||
| 15:00-16:40 | SY 11 | SY 12 | SY 13 | OP 04 | OP 05 |
| (15:00-17:00) Accreditation system for the clinical laboratory | Education track II | AACC-KSLM Select Session Emerging clinical applications for circulating DNA analysis |
Diagnostic genetics 1 & Diagnostic hematology | Clinical chemistry 2 & Diagnostic immunology | |
| 17:00-18:00 | KS 02 | EW 06 | |||
| (17:00-17:40) Strategies to optimize medical laboratory for patient care in the era of universal coverage |
 Next molecular diagnostics solution in Sysmex |
||||
| 18:00-20:00 | Banquet (Walkerhill Theatre, B1) |
||||
| Time | Vista Hall 1 (B2) | Walker Hall 1 (1F) | Walker Hall 2 (1F) | Cosmos Hall (3F) | Art Hall (4F) |
|---|---|---|---|---|---|
| 08:00-08:40 | KS 03 | ||||
| Bioactive lipids in laboratory medicine | |||||
| 09:00-10:40 | SY 14 | SY 15 | SY 16 | SY 17 (Kor) | OP 06 |
| CLSI-KSLM Session Customer focused documents of CLSI |
Recent trends in clinical chemistry for optimal patients care | Updates in laboratory hematology | KCDC-KSLM Session Legislation for diagnostic tests: National regulation or supports |
Diagnostic genetics 2 | |
| 10:40-11:00 | Break | ||||
| 11:00-12:00 | PL 03 | ||||
| The fight against antimicrobial resistance: Are we doing right? | |||||
| 12:00-13:00 | EW 07 | EW 08 | EW 09 | EW 10 | EW 11 |
 Clinical utility of prostate health index (phi) for prostate cancer detection and prediction of high risk prostate cancer |
 Diagnosis and treatment of latent tuberculosis infection |
 Measurement and clinical application of HbA1c in Japan |
 Clinical implications of syndromic, rapid, sample-to-answer molecular infectious disease testing |
 Illumina’s amplicon-based BRCA1/BRCA2 analysis: Faster and more reliable |
|
| 13:00-13:40 | KS 04 | ||||
| Integrative analyses of microbiota, immunity & environment can transform (laboratory) medicine | |||||
| 14:00-15:40 | SY 18 | SY 19 | SY 20 | ||
| (14:00-15:30) ESCMID-KSLM Session Precision medicine in infectious diseases |
Guidelines on clinical tests for patient care | (14:00-15:30) Role of specialists in transfusion medicine |
|||
| 15:40-16:00 | KSLM General Assembly | ||||
